A detailed history of Jmac Enterprises LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jmac Enterprises LLC holds 1,638 shares of LLY stock, worth $1.45 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,638
Previous 1,629 0.55%
Holding current value
$1.45 Million
Previous $1.27 Million 17.05%
% of portfolio
0.27%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $6,523 - $8,181
9 Added 0.55%
1,638 $1.48 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $116,663 - $156,079
-197 Reduced 10.79%
1,629 $1.27 Million
Q4 2023

Jan 26, 2024

BUY
$525.19 - $619.13 $124,470 - $146,733
237 Added 14.92%
1,826 $1.06 Million
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $3,912 - $5,393
9 Added 0.57%
1,589 $853,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $355,263 - $440,883
1,580 New
1,580 $379,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jmac Enterprises LLC Portfolio

Follow Jmac Enterprises LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jmac Enterprises LLC with notifications on news.